Silexion Therapeutics LTD Statistics
Share Statistics
Silexion Therapeutics LTD has -
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 764 |
| FTD / Avg. Volume | 1.69% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | -0.01 |
| P/FCF Ratio | n/a |
| PEG Ratio | undefined |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Silexion Therapeutics LTD.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.27,
with a Debt / Equity ratio of undefined.
| Current Ratio | 2.27 |
| Quick Ratio | 2.27 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | undefined |
Financial Efficiency
Return on Equity is 0.32% and Return on Invested Capital is 39.63%.
| Return on Equity | 0.32% |
| Return on Assets | -0.94% |
| Return on Invested Capital | 39.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 32K |
| Effective Tax Rate | -0.01% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is -0.11, so Silexion Therapeutics LTD's
price volatility has been lower than the market average.
| Beta | -0.11 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 54.33 |
| Average Volume (20 Days) | 45,278 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.68M |
| Net Income | -4.94M |
| EBITDA | -4.64M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.39 |
Full Income StatementBalance Sheet
The company has 4.59M in cash and 171K in
debt, giving a net cash position of 4.42M.
| Cash & Cash Equivalents | 4.59M |
| Total Debt | 171K |
| Net Cash | 4.42M |
| Retained Earnings | -26.81M |
| Total Assets | 3.09M |
| Working Capital | -536K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -4.53M
and capital expenditures -12K, giving a free cash flow of -4.54M.
| Operating Cash Flow | -4.53M |
| Capital Expenditures | -12K |
| Free Cash Flow | -4.54M |
| FCF Per Share | -6.67 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
